Loos WJ - Search Results

1

The relevance of microdialysis for clinical on:cology.

Kitzen JJ, Verweij J, Wiemer EA, Loos WJ. Kitzen JJ, et al. Among authors: loos wj. Curr Clin Pharmacol. 2006 Sep;1(3):255-63. doi: 10.2174/157488406778249316. Curr Clin Pharmacol. 2006. PMID: 18666750 Review.

2

Clinical pharmacokinetics of unbound docetaxel: role of polysorbate 80 and serum proteins.

Loos WJ, Baker SD, Verweij J, Boonstra JG, Sparreboom A. Loos WJ, et al. Clin Pharmacol Ther. 2003 Oct;74(4):364-71. doi: 10.1016/S0009-9236(03)00222-4. Clin Pharmacol Ther. 2003. PMID: 14534523

3

Application of prolonged microdialysis sampling in carboplatin-treated cancer patients.

Konings IR, Engels FK, Sleijfer S, Verweij J, Wiemer EA, Loos WJ. Konings IR, et al. Among authors: loos wj. Cancer Chemother Pharmacol. 2009 Aug;64(3):509-16. doi: 10.1007/s00280-008-0898-0. Epub 2008 Dec 20. Cancer Chemother Pharmacol. 2009. PMID: 19096847 Free PMC article.

4

Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study.

Konings IR, Sleijfer S, Mathijssen RH, de Bruijn P, Ghobadi Moghaddam-Helmantel IM, van Dam LM, Wiemer EA, Verweij J, Loos WJ. Konings IR, et al. Among authors: loos wj. Cancer Chemother Pharmacol. 2011 May;67(5):1055-62. doi: 10.1007/s00280-010-1400-3. Epub 2010 Jul 23. Cancer Chemother Pharmacol. 2011. PMID: 20652702 Free PMC article. Clinical Trial.

5

Determination of topotecan in human whole blood and unwashed erythrocytes by high-performance liquid chromatography.

Loos WJ, van Zomeren DM, Gelderblom H, Verweij J, Nooter K, Stoter G, Sparreboom A. Loos WJ, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jan 5;766(1):99-105. doi: 10.1016/s0378-4347(01)00432-7. J Chromatogr B Analyt Technol Biomed Life Sci. 2002. PMID: 11820300

6

Phase I and pharmacologic study of liposomal lurtotecan, NX 211: urinary excretion predicts hematologic toxicity.

Kehrer DF, Bos AM, Verweij J, Groen HJ, Loos WJ, Sparreboom A, de Jonge MJ, Hamilton M, Cameron T, de Vries EG. Kehrer DF, et al. Among authors: loos wj. J Clin Oncol. 2002 Mar 1;20(5):1222-31. doi: 10.1200/JCO.2002.20.5.1222. J Clin Oncol. 2002. PMID: 11870164 Clinical Trial.

7

Pharmacology of topoisomerase I inhibitors irinotecan (CPT-11) and topotecan.

Mathijssen RH, Loos WJ, Verweij J, Sparreboom A. Mathijssen RH, et al. Among authors: loos wj. Curr Cancer Drug Targets. 2002 Jun;2(2):103-23. doi: 10.2174/1568009023333890. Curr Cancer Drug Targets. 2002. PMID: 12188913 Review.

8

Red blood cells: a neglected compartment in topotecan pharmacokinetic analysis.

Loos WJ, Gelderblom H, Verweij J, van Boven-van Zomeren DM, Nooter K, Stoter G, Sparreboom A. Loos WJ, et al. Anticancer Drugs. 2003 Mar;14(3):227-32. doi: 10.1097/00001813-200303000-00006. Anticancer Drugs. 2003. PMID: 12634617 Clinical Trial.

9

Pharmacological effects of formulation vehicles : implications for cancer chemotherapy.

ten Tije AJ, Verweij J, Loos WJ, Sparreboom A. ten Tije AJ, et al. Among authors: loos wj. Clin Pharmacokinet. 2003;42(7):665-85. doi: 10.2165/00003088-200342070-00005. Clin Pharmacokinet. 2003. PMID: 12844327 Review.

10

Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxel.

Engels FK, Ten Tije AJ, Baker SD, Lee CK, Loos WJ, Vulto AG, Verweij J, Sparreboom A. Engels FK, et al. Among authors: loos wj. Clin Pharmacol Ther. 2004 May;75(5):448-54. doi: 10.1016/j.clpt.2004.01.001. Clin Pharmacol Ther. 2004. PMID: 15116057 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters